Cancer Network spoke with Ruth Oratz, MD, a medical oncologist at NYU Langone Perlmutter Cancer Center in New York City, about the use of PARP inhibitors for breast cancer.
Cancer Network spoke with Ruth Oratz, MD, a medical oncologist and breast cancer specialist at NYU Langone Perlmutter Cancer Center in New York City, about the use of poly (ADP-ribose) polymerase inhibitors for patients diagnosed with breast cancer.
